TGF-beta-producing CD4(+) mediastinal lymph node cells obtained from mice tracheally tolerized to ovalbumin (OVA) suppress both Th1-and Th2-induced cutaneous inflammatory responses to OVA by different mechanisms
T. Terui et al., TGF-beta-producing CD4(+) mediastinal lymph node cells obtained from mice tracheally tolerized to ovalbumin (OVA) suppress both Th1-and Th2-induced cutaneous inflammatory responses to OVA by different mechanisms, J IMMUNOL, 167(7), 2001, pp. 3661-3667
Advances in the treatment of allergic disorders require elucidation of the
autoregulatory immune systems induced in averting detrimental inflammatory
responses against invading foreign Ags. We previously reported that excessi
ve Ags intruding through the airway mucosa induce a subset of regulatory CD
4(+) T cells secreting TGF-beta in the regional mediastinal lymph nodes (ML
Ns), which inhibits Th2 cells and subsequent eosinophilic inflammation in t
he trachea. In the present experiments we examined whether and in what mech
anisms TGF-beta -secreting CD4(+) T cells in the MLNs regulate Th cell-medi
ated skin inflammation using a previously established murine model. Th1 or
Th2 cells injected s.c. into ear lobes of naive mice induced swelling, wher
eas the concomitant local injection of MLN cells suppressed the inflammatio
n. The suppressor activities of MLN cells were markedly neutralized by anti
-TGF-beta mAb and were mimicked by rTGF-beta. The MLN cell- and rTGF-beta -
induced inhibition was reversed by anti-IL-10 mAb significantly in Th1-indu
ced inflammation and only partially in Th2-induced inflammation. rIL-10 red
uced Th-induced ear swelling, although higher doses of rIL-10 were required
in Th2-induced one. Thus, allergen-specific TGF-beta -producing CD4(+) T c
ells induced in the respiratory tract controlled cutaneous inflammatory res
ponses by Th1 or Th2 cells either directly by TGF-beta or indirectly throug
h IL-10 induction. From a clinical standpoint, these observations might exp
lain the mechanism of spontaneous regression in some patients with atopic d
ermatitis, which exhibits both Th1- and Th2-mediated skin inflammation in r
esponse to airborne protein Ags.